PGS Sample Set (PSS) large_stringlengths 9 9 | Polygenic Score (PGS) ID large_stringlengths 9 2.77k | Number of Individuals int64 1 5.33M | Number of Cases float64 0 389k ⌀ | Number of Controls float64 0 1.14M ⌀ | Percent of Participants Who are Male float64 0 100 ⌀ | Sample Age large_stringclasses 733
values | Broad Ancestry Category large_stringclasses 73
values | Ancestry (e.g. French, Chinese) large_stringclasses 90
values | Country of Recruitment large_stringclasses 140
values | Additional Ancestry Description large_stringclasses 131
values | Phenotype Definitions and Methods large_stringclasses 798
values | Followup Time large_stringclasses 141
values | GWAS Catalog Study ID (GCST...) large_stringclasses 8
values | Source PubMed ID (PMID) float64 1.25M 39.9M ⌀ | Source DOI large_stringclasses 13
values | Cohort(s) large_stringclasses 460
values | Additional Sample/Cohort Information large_stringclasses 245
values |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PSS000317 | PGS000197 | 243 | 8 | 235 | 32 | null | European | null | USA | null | Setting III: Based on ICD codes and final diagnosis in medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:7.0;unit:years | null | null | null | PHB | null |
PSS000318 | PGS000196 | 245 | 62 | 183 | 32 | null | European | null | USA | null | Setting II: Based on ICD codes and review of medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:8.0;unit:years | null | null | null | PHB | null |
PSS000319 | PGS000196 | 243 | 7 | 236 | 32 | null | European | null | USA | null | Setting III: Based on ICD codes and final diagnosis in medical records from Partners HealthCare Biobank; controls = other non-matching arthritis diseases | median:7.0;unit:years | null | null | null | PHB | null |
PSS000320 | PGS000199 | 1,211 | 387 | 824 | 43 | null | European, African unspecified, Asian unspecified, NR | null | USA | Primarily European, African and Asian ancestry | Setting I: Based on ICD codes and expert opinion (ACR2010 criteria), in eMERGE network EMR database from Stanaway 2018; controls = other non-matching arthritis diseases | median:16.0;unit:years | null | null | 10.1002/gepi.22167 | eMERGE | null |
PSS000321 | PGS000198 | 1,211 | 52 | 1,159 | 43 | null | European, African unspecified, Asian unspecified, NR | null | USA | Primarily European, African and Asian ancestry | Setting I: Based on ICD codes and expert opinion (ACR2010 criteria), in eMERGE network EMR database from Stanaway 2018; controls = other non-matching arthritis diseases | median:16.0;unit:years | null | null | 10.1002/gepi.22167 | eMERGE | null |
PSS000322 | PGS000194, PGS000195 | 1,211 | 574 | 637 | 43 | null | European, African unspecified, Asian unspecified, NR | null | USA | Primarily European, African and Asian ancestry | Setting I: Based on ICD codes and expert opinion (ACR2010 criteria), in eMERGE network EMR database from Stanaway 2018; controls = other non-matching arthritis diseases | median:16.0;unit:years | null | null | 10.1002/gepi.22167 | eMERGE | null |
PSS000323 | PGS000197 | 1,211 | 65 | 1,146 | 43 | null | European, African unspecified, Asian unspecified, NR | null | USA | Primarily European, African and Asian ancestry | Setting I: Based on ICD codes and expert opinion (ACR2010 criteria), in eMERGE network EMR database from Stanaway 2018; controls = other non-matching arthritis diseases | median:16.0;unit:years | null | null | 10.1002/gepi.22167 | eMERGE | null |
PSS000324 | PGS000196 | 1,211 | 133 | 1,078 | 43 | null | European, African unspecified, Asian unspecified, NR | null | USA | Primarily European, African and Asian ancestry | Setting I: Based on ICD codes and expert opinion (ACR2010 criteria), in eMERGE network EMR database from Stanaway 2018; controls = other non-matching arthritis diseases | median:16.0;unit:years | null | null | 10.1002/gepi.22167 | eMERGE | null |
PSS000328 | PGS000200 | 5,104 | 235 | 4,869 | 44.8 | mean:43.9;sd:11.3;unit:years | European | Finnish | Finland | null | ACS was defined as MI, unstable angina or death due to CHD. | mean:19.0;unit:years | null | null | null | FINRISK | FINRISK 1992 |
PSS000328 | PGS000200 | 6,567 | 229 | 6,338 | 45.8 | mean:46.8;sd:12.9;unit:years | European | Finnish | Finland | null | ACS was defined as MI, unstable angina or death due to CHD. | mean:14.0;unit:years | null | null | null | FINRISK97 | FINRISK 1997 |
PSS000328 | PGS000200 | 7,330 | 148 | 7,182 | 45 | mean:47.5;sd:13.0;unit:years | European | Finnish | Finland | null | ACS was defined as MI, unstable angina or death due to CHD. | mean:9.0;unit:years | null | null | null | FINRISK | FINRISK 2002 |
PSS000328 | PGS000200 | 5,123 | 119 | 5,004 | 46.3 | mean:50.0;sd:11.7;unit:years | European | Finnish | Finland | null | ACS was defined as MI, unstable angina or death due to CHD. | mean:8.0;unit:years | null | null | null | Health2000 | null |
PSS000329 | PGS000200 | 5,104 | 343 | 4,761 | 44.8 | mean:43.9;sd:11.3;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. | mean:19.0;unit:years | null | null | null | FINRISK | FINRISK 1992 |
PSS000329 | PGS000200 | 6,567 | 344 | 6,223 | 45.8 | mean:46.8;sd:12.9;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. | mean:14.0;unit:years | null | null | null | FINRISK97 | FINRISK 1997 |
PSS000329 | PGS000200 | 7,330 | 209 | 7,121 | 45 | mean:47.5;sd:13.0;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. | mean:9.0;unit:years | null | null | null | FINRISK | FINRISK 2002 |
PSS000329 | PGS000200 | 5,123 | 197 | 4,926 | 46.3 | mean:50.0;sd:11.7;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. | mean:8.0;unit:years | null | null | null | Health2000 | null |
PSS000330 | PGS000200 | 5,104 | 501 | 4,603 | 44.8 | mean:43.9;sd:11.3;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. CVD included CHD and ischemic stroke events. | mean:19.0;unit:years | null | null | null | FINRISK | FINRISK 1992 |
PSS000330 | PGS000200 | 6,567 | 499 | 6,068 | 45.8 | mean:46.8;sd:12.9;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. CVD included CHD and ischemic stroke events. | mean:14.0;unit:years | null | null | null | FINRISK97 | FINRISK 1997 |
PSS000330 | PGS000200 | 7,330 | 291 | 7,039 | 45 | mean:47.5;sd:13.0;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. CVD included CHD and ischemic stroke events. | mean:9.0;unit:years | null | null | null | FINRISK | FINRISK 2002 |
PSS000330 | PGS000200 | 5,123 | 261 | 4,862 | 46.3 | mean:50.0;sd:11.7;unit:years | European | Finnish | Finland | null | CHD was defined as myocardial infarction, unstable angina pectoris, coronary revascularization (coronary artery bypass graft or percutaneous transluminal coronary angioplasty), or death due to CHD. CVD included CHD and ischemic stroke events. | mean:8.0;unit:years | null | null | null | Health2000 | null |
PSS000331 | PGS000011, PGS000013, PGS000018, PGS000200 | 7,597 | 838 | 6,759 | 31 | mean:43.6;sd:12.5;unit:years | African American or Afro-Caribbean | null | USA | null | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasion... | median:9.2;iqr:[5.5,13.0];unit:years | null | null | null | eMERGE|Columbia|KP|Nugene|BioVU|PHB|BioMe | right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000332 | PGS000011, PGS000013, PGS000018, PGS000200 | 7,070 | 311 | 6,759 | 31 | mean:43.6;sd:12.5;unit:years | African American or Afro-Caribbean | null | USA | null | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasion... | median:9.2;iqr:[5.5,13.0];unit:years | null | null | null | eMERGE|Columbia|KP|Nugene|BioVU|PHB|BioMe | right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000333 | PGS000011, PGS000013, PGS000018, PGS000200 | 45,645 | 8,108 | 37,537 | 44.6 | mean:49.0;sd:14.1;unit:years | European | null | USA | null | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasion... | median:11.7;iqr:[6.0,18.5];unit:years | null | null | null | eMERGE|Columbia|CCHMC|MyCode|KP|Marshfield|Nugene|BioVU|MAYO|PHB|BioMe | right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000334 | PGS000011, PGS000013, PGS000018, PGS000200 | 39,758 | 2,221 | 37,537 | 44.6 | mean:49.0;sd:14.1;unit:years | European | null | USA | null | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasion... | median:11.7;iqr:[6.0,18.5];unit:years | null | null | null | eMERGE|Columbia|CCHMC|MyCode|KP|Marshfield|Nugene|BioVU|MAYO|PHB|BioMe | right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000335 | PGS000011, PGS000013, PGS000018, PGS000200 | 2,493 | 419 | 2,074 | 36.2 | mean:41.1;sd:13.2;unit:years | Hispanic or Latin American | null | USA | null | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasion... | median:10.4;iqr:[5.7,14.7];unit:years | null | null | null | eMERGE|Columbia|KP|Nugene|BioVU|MAYO|PHB|BioMe | right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000336 | PGS000011, PGS000013, PGS000018, PGS000200 | 2,194 | 120 | 2,074 | 36.2 | mean:41.1;sd:13.2;unit:years | Hispanic or Latin American | null | USA | null | CHD was defined as occurrence of either myocardial infarction (MI) or coronary revascularization events (such as percutaneous coronary intervention or coronary artery bypass grafting) using ICD codes. Individuals with MI were defined as those whose EHR included at least two related diagnostic codes on separate occasion... | median:10.4;iqr:[5.7,14.7];unit:years | null | null | null | eMERGE|Columbia|KP|Nugene|BioVU|MAYO|PHB|BioMe | right censored at age 75 years or at the age of last observation (whichever was first) |
PSS000339 | PGS000201, PGS000203, PGS000205 | 7,599 | null | null | 47.16 | mean:36.94;range:[12.0,91.0];sd:14.77;unit:years | European | null | USA | null | null | null | null | 12,875,050 | null | COGA | null |
PSS000340 | PGS000202, PGS000204, PGS000206 | 1,251 | null | null | 45.6 | mean:21.9;range:[21.0,26.0];sd:0.77;unit:years | European | Finnish | Finland | null | null | null | null | 23,298,696 | null | FinnTwin12 | Twin Study |
PSS000341 | PGS000208 | 130,279 | 723 | 129,556 | 46.411931 | null | European | null | Iceland | null | Cases were ascertained using ICD-10 C73 (PTC, FTC, cancer/carcinoma, and rare nonmedullary) | null | null | null | null | deCODE | null |
PSS000342 | PGS000207 | 3,137 | 1,544 | 1,593 | 26.075869 | null | European | null | USA | null | Histologically confirmed papillary or follicular thyroid carcinoma (PTC) patients (including traditional PTC and follicular variant PTC) | null | null | null | null | null | null |
PSS000343 | PGS000209 | 408,479 | 534 | 407,945 | 45.973477 | null | European | null | UK | null | Cases were ascertained using ICD-10 C73 (PTC, FTC, cancer/carcinoma, and rare nonmedullary) | null | null | null | null | UKB | null |
PSS000344 | PGS000210 | 2,466 | 910 | 1,556 | null | null | African American or Afro-Caribbean | null | USA | null | null | null | null | null | null | COPDGene | null |
PSS000345 | PGS000210 | 75,580 | 69,567 | 6,013 | null | null | East Asian | Chinese | China | null | FEV1/FVC<0.7 and FEV1<80% predicted (i.e. corresponding to GOLD 2-4 standards) | null | null | null | null | CKB | null |
PSS000346 | PGS000210 | 10,894 | 6,979 | 3,915 | null | null | European | null | USA, Norway, NR | null | null | null | null | null | null | COPDGene|ECLIPSE|GenKOLS|NETT|NAS|SPIROMICS | null |
PSS000347 | PGS000210 | 4,225 | 172 | 4,053 | null | null | African unspecified | null | UK | null | FEV1/FVC<0.7 and FEV1<80% predicted (i.e. corresponding to GOLD 2-4 standards) | null | null | null | null | UKB | null |
PSS000348 | PGS000210 | 303,570 | 288,467 | 15,103 | null | null | European | null | UK | null | FEV1/FVC<0.7 and FEV1<80% predicted (i.e. corresponding to GOLD 2-4 standards) | null | null | null | null | UKB | null |
PSS000349 | PGS000210 | 6,033 | 5,752 | 281 | null | null | Other admixed ancestry | null | UK | null | FEV1/FVC<0.7 and FEV1<80% predicted (i.e. corresponding to GOLD 2-4 standards) | null | null | null | null | UKB | null |
PSS000350 | PGS000210 | 6,358 | 6,046 | 312 | null | null | South Asian | null | UK | null | FEV1/FVC<0.7 and FEV1<80% predicted (i.e. corresponding to GOLD 2-4 standards) | null | null | null | null | UKB | null |
PSS000351 | PGS000210 | 72,796 | null | null | null | null | East Asian | Chinese | China | null | null | null | null | null | null | CKB | null |
PSS000352 | PGS000210 | 4,225 | null | null | null | null | African unspecified | null | UK | null | null | null | null | null | null | UKB | null |
PSS000353 | PGS000210 | 1,208 | null | null | null | null | Other admixed ancestry | Admixed African (unspecified) and European | UK | null | null | null | null | null | null | UKB | null |
PSS000354 | PGS000210 | 1,607 | null | null | null | null | East Asian | null | UK | null | null | null | null | null | null | UKB | null |
PSS000355 | PGS000210 | 303,570 | null | null | null | null | European | null | UK | null | null | null | null | null | null | UKB | null |
PSS000356 | PGS000210 | 6,033 | null | null | null | null | Other admixed ancestry | null | UK | null | null | null | null | null | null | UKB | null |
PSS000357 | PGS000210 | 6,358 | null | null | null | null | South Asian | null | UK | null | null | null | null | null | null | UKB | null |
PSS000358 | PGS000211 | 336 | 336 | 0 | 66 | range:[35.0,85.0];unit:years | European | null | Norway | null | UPDRS motor severity was estimated as a mean value acrosseach patient’s recordings, relative to the rest of the data | mean:5946.0;range:[1574.0,13992.0];sd:2299.0;unit:days | null | null | 10.1016/j.neurobiolaging.2012.10.019 | null | Testing dataset genotyped as part of a larger study of a total of 1380 patients with idiopathic PD and 1295 control subjects by 5 collaborating groups in Norway and Sweden. (https://www.sciencedirect.com/science/article/abs/pii/S0197458012005301?showall%3Dtrue%26via%3Dihub) |
PSS000359 | PGS000004, PGS000005, PGS000215 | 21,533 | 718 | 20,815 | 0 | null | European | null | Israel, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Republic of Ireland, Russian Federation, Spain, Sweden, The former Yugoslav Republic of Macedonia, U.K., NR, Canada, U.S., Australia, New Zealand | null | Defined intrinsic-like breast cancer subtypes based on tumor status of ER, PR, HER2 and grade: (4) HER2-enriched-like (ER- and PR-, HER2+) | null | null | null | null | BCAC|pKARMA|PLCO|UKBGS|MMHS|SISTER | Heldout subset (20%) of the BCAC consortium data |
PSS000360 | PGS000004, PGS000005, PGS000212 | 28,140 | 7,325 | 20,815 | 0 | null | European | null | Israel, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Republic of Ireland, Russian Federation, Spain, Sweden, The former Yugoslav Republic of Macedonia, U.K., NR, Canada, U.S., Australia, New Zealand | null | Defined intrinsic-like breast cancer subtypes based on tumor status of ER, PR, HER2 and grade: (1) luminal A-like (ER+ and/or PR+, HER2-, grade 1 & 2); | null | null | null | null | BCAC|pKARMA|PLCO|UKBGS|MMHS|SISTER | Heldout subset (20%) of the BCAC consortium data |
PSS000361 | PGS000004, PGS000005, PGS000213 | 22,594 | 1,779 | 20,815 | 0 | null | European | null | Israel, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Republic of Ireland, Russian Federation, Spain, Sweden, The former Yugoslav Republic of Macedonia, U.K., NR, Canada, U.S., Australia, New Zealand | null | Defined intrinsic-like breast cancer subtypes based on tumor status of ER, PR, HER2 and grade: (2) luminal B/HER2-negative-like (ER+ and/or PR+, HER2-, grade 3) | null | null | null | null | BCAC|pKARMA|PLCO|UKBGS|MMHS|SISTER | Heldout subset (20%) of the BCAC consortium data |
PSS000362 | PGS000004, PGS000005, PGS000214 | 22,497 | 1,682 | 20,815 | 0 | null | European | null | Israel, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Republic of Ireland, Russian Federation, Spain, Sweden, The former Yugoslav Republic of Macedonia, U.K., NR, Canada, U.S., Australia, New Zealand | null | Defined intrinsic-like breast cancer subtypes based on tumor status of ER, PR, HER2 and grade: (3) luminal B-like (ER+ and/or PR+, HER2+); | null | null | null | null | BCAC|pKARMA|PLCO|UKBGS|MMHS|SISTER | Heldout subset (20%) of the BCAC consortium data |
PSS000363 | PGS000004, PGS000005, PGS000216 | 22,821 | 2,006 | 20,815 | 0 | null | European | null | Israel, Belgium, Denmark, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Republic of Ireland, Russian Federation, Spain, Sweden, The former Yugoslav Republic of Macedonia, U.K., NR, Canada, U.S., Australia, New Zealand | null | Defined intrinsic-like breast cancer subtypes based on tumor status of ER, PR, HER2 and grade: (5) triple-negative ( ER-, PR-, HER2-). | null | null | null | null | BCAC|pKARMA|PLCO|UKBGS|MMHS|SISTER | Heldout subset (20%) of the BCAC consortium data |
PSS000364 | PGS000217, PGS000218, PGS000219, PGS000220, PGS000221, PGS000222, PGS000223, PGS000224, PGS000225, PGS000226, PGS000227, PGS000228, PGS000229, PGS000230, PGS000231, PGS000232, PGS000233, PGS000234, PGS000235, PGS000236, PGS000237, PGS000238, PGS000239, PGS000240, PGS000241, PGS000242, PGS000243, PGS000244, PGS000245, P... | 4,678 | null | null | null | null | European | Swedish | Sweden | null | null | null | null | null | null | MDC | null |
PSS000365 | PGS000013, PGS000296 | 247 | 247 | null | 90.7 | mean:34.0;iqr:[30.0,35.0];unit:years | South Asian | null | Bangladesh | null | Case-control study of first-onset acute myocardial infarction | null | null | null | 10.1007/s10654-015-0037-2 | BRAVE | null |
PSS000365 | PGS000013, PGS000296 | 244 | null | 244 | 90.2 | mean:33.0;iqr:[30.0,35.0];unit:years | South Asian | null | Bangladesh | null | Case-control study of first-onset acute myocardial infarction | null | null | null | 10.1007/s10654-015-0037-2 | BRAVE | null |
PSS000366 | PGS000013, PGS000296 | 1,800 | 1,800 | null | 90.2 | mean:54.0;iqr:[46.0,60.0];unit:years | South Asian | null | India | null | Cases composed of men and women diagnosed with coronary artery disease. Controls were selected from consenting men and women without any form of heart disease. | null | null | null | null | MedGenome | null |
PSS000366 | PGS000013, PGS000296 | 1,163 | null | 1,163 | 76.4 | mean:55.0;iqr:[49.0,62.0];unit:years | South Asian | null | India | null | Cases composed of men and women diagnosed with coronary artery disease. Controls were selected from consenting men and women without any form of heart disease. | null | null | null | null | MedGenome | null |
PSS000367 | PGS000013 | 398 | 398 | null | 86.7 | mean:60.6;iqr:[54.4,66.1];unit:years | South Asian | null | United Kingdom | null | Ascertainment of coronary artery disease was based on self-report or hospital admission diagnosis. This included individuals with ICD-9 codes of 410.X, 411.0, 412.X, or 429.79, or ICD-10 codes of I21.X, I22.X, I23.X, I24.1, or I25.2 in hospitalization records. Coronary revascularization was assessed based on an OPCS-4 ... | null | null | null | null | UKB | null |
PSS000367 | PGS000013 | 6,846 | null | 6,846 | 52.1 | mean:52.8;iqr:[46.3,60.2];unit:years | South Asian | null | United Kingdom | null | Ascertainment of coronary artery disease was based on self-report or hospital admission diagnosis. This included individuals with ICD-9 codes of 410.X, 411.0, 412.X, or 429.79, or ICD-10 codes of I21.X, I22.X, I23.X, I24.1, or I25.2 in hospitalization records. Coronary revascularization was assessed based on an OPCS-4 ... | null | null | null | null | UKB | null |
PSS000368 | PGS000024 | 7,798 | 305 | 7,493 | 50.859195 | range:[3.0,4.0];unit:years | NR | null | USA, Finland, Germany, Sweden | null | TEDDY children were followed prospectively from 3–4 months of age, with visits every 3 months until 4 years of age. Each evaluation tested the three islet antibodies (GADA, IA2A and IAA), changes in family history, as well as other measurements specified by the TEDDY protocol. After 4 years of age, children with any is... | median:9.3;range:[0.0833,14.0];unit:years | null | null | 10.1196/annals.1447.062 | TEDDY | From 2004–2010, 424,788 newborns were screened at six US and European centers for high-risk HLA genotypes. TEDDY then enrolled 8,676 eligible infants with the intent to follow them until 15 years of age. The three major eligible HLA DR–DQ haplotypes are DR3–DQA1*0501–DQB1*0201, DR4–DQA1*0301–DQB1*0302 and DR8–DQA1*0401... |
PSS000369 | PGS000297, PGS000298, PGS000300 | 334 | null | null | 69.2 | mean:11.1;sd:0.48;unit:years | European | null | The Netherlands | null | Individuals who have been referred to a child psychiatric outpatient clinic in the Northern Netherlands before the age of 11. We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also cal... | null | null | null | null | TRAILS|TRAILSCC | TRAILS Clinical Cohort |
PSS000370 | PGS000297, PGS000298 | 329 | null | null | 69.2 | mean:12.81;sd:0.59;unit:years | European | null | The Netherlands | null | Individuals who have been referred to a child psychiatric outpatient clinic in the Northern Netherlands before the age of 11. We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also cal... | null | null | null | null | TRAILS|TRAILSCC | TRAILS Clinical Cohort |
PSS000371 | PGS000297, PGS000298, PGS000299, PGS000300, PGS000301, PGS000302, PGS000304 | 288 | null | null | 69.2 | mean:15.83;sd:0.6;unit:years | European | null | The Netherlands | null | Individuals who have been referred to a child psychiatric outpatient clinic in the Northern Netherlands before the age of 11. We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also cal... | null | null | null | null | TRAILS|TRAILSCC | TRAILS Clinical Cohort |
PSS000372 | PGS000297, PGS000298, PGS000299 | 265 | null | null | 69.2 | mean:19.2;sd:0.66;unit:years | European | null | The Netherlands | null | Individuals who have been referred to a child psychiatric outpatient clinic in the Northern Netherlands before the age of 11. We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also cal... | null | null | null | null | TRAILS|TRAILSCC | TRAILS Clinical Cohort |
PSS000373 | PGS000297, PGS000298, PGS000299 | 245 | null | null | 69.2 | mean:22.04;sd:0.69;unit:years | European | null | The Netherlands | null | Individuals who have been referred to a child psychiatric outpatient clinic in the Northern Netherlands before the age of 11. We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also cal... | null | null | null | null | TRAILS|TRAILSCC | TRAILS Clinical Cohort |
PSS000374 | PGS000297, PGS000298, PGS000300 | 1,318 | null | null | 47.6 | mean:11.1;unit:years | European | null | The Netherlands | null | We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also calculated. We measured waist circumference at the midpoint between the lower costal margin and the iliac crest. The hip circumfe... | null | null | null | null | TRAILS | null |
PSS000375 | PGS000297, PGS000298 | 1,313 | null | null | 47.6 | mean:13.5;unit:years | European | null | The Netherlands | null | We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also calculated. We measured waist circumference at the midpoint between the lower costal margin and the iliac crest. The hip circumfe... | null | null | null | null | TRAILS | null |
PSS000376 | PGS000297, PGS000298, PGS000299, PGS000300, PGS000301, PGS000302, PGS000303, PGS000304, PGS000305, PGS000306, PGS000307, PGS000308, PGS000309, PGS000310, PGS000311, PGS000312, PGS000313, PGS000314, PGS000315 | 1,354 | null | null | 47.562777 | mean:16.22;sd:0.66;unit:years | European | null | The Netherlands | null | We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also calculated. We measured waist circumference at the midpoint between the lower costal margin and the iliac crest. The hip circumfe... | null | null | null | null | TRAILS | null |
PSS000377 | PGS000297, PGS000298, PGS000299 | 1,174 | null | null | 47.6 | mean:19.2;unit:years | European | null | The Netherlands | null | We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also calculated. We measured waist circumference at the midpoint between the lower costal margin and the iliac crest. The hip circumfe... | null | null | null | null | TRAILS | null |
PSS000378 | PGS000297, PGS000298, PGS000299 | 1,095 | null | null | 47.6 | mean:22.4;unit:years | European | null | The Netherlands | null | We measured weight and height using regularly calibrated equipment (scales and stadiometer models 770 and 214, respectively; Seca, Hamburg, Germany). Body mass index (BMI; in kg/m2) was also calculated. We measured waist circumference at the midpoint between the lower costal margin and the iliac crest. The hip circumfe... | null | null | null | null | TRAILS | null |
PSS000381 | PGS000316 | 40 | 0 | 40 | 48 | mean:4.9;sd:4.0;unit:years | NR | null | Canada | null | Control subjects (n = 40) were paediatric general gastroenterology patients whom were negative for coeliac disease by both intestinal biopsy and negative tissue transglutaminase serology. | null | null | null | null | STOLLERY_CC | null |
PSS000381 | PGS000316 | 63 | 63 | 0 | 63 | mean:8.6;sd:3.9;unit:years | NR | null | Canada | null | Diagnosis of coeliac disease was made by a modification of European serological diagnostic guidelines for patients referred to a tertiary paediatric clinic in Alberta, Canada, for consideration of coeliac disease diagnosis | null | null | null | null | STOLLERY_CC | null |
PSS000381 | PGS000316 | 51 | 51 | 0 | 57 | mean:7.5;sd:3.8;unit:years | NR | null | Canada | null | Diagnosis of coeliac disease was made by endoscopy for patients referred to a tertiary paediatric clinic in Alberta, Canada, for consideration of coeliac disease diagnosis | null | null | null | null | STOLLERY_CC | null |
PSS000382 | PGS000316 | 379,767 | 1,237 | 378,530 | null | null | European | null | null | null | Coeliac disease cases were identified using either hospital admission code and/or self‐reported coeliac disease. | null | null | null | null | UKB | null |
PSS000383 | PGS000116 | 147,985 | 1,350 | 146,635 | null | range:[40.0,55.0];unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000384 | PGS000117 | 147,985 | 10,899 | 137,086 | null | range:[40.0,55.0];unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000385 | PGS000116 | 147,110 | 1,339 | 145,771 | null | range:[40.0,55.0];unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000386 | PGS000117 | 147,110 | 2,826 | 144,284 | null | range:[40.0,55.0];unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000387 | PGS000116 | 204,675 | 4,922 | 199,753 | null | range:[55.0,69.0];unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000388 | PGS000117 | 204,675 | 2,854 | 201,821 | null | range:[55.0,69.0];unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000389 | PGS000116 | 203,620 | 4,900 | 198,720 | null | range:[55.0,69.0];unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000390 | PGS000117 | 203,620 | 10,824 | 192,796 | null | range:[55.0,69.0];unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000391 | PGS000116 | 147,363 | 4,493 | 142,870 | 100 | mean:55.79;sd:8.35;unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000392 | PGS000117 | 147,363 | 8,595 | 138,768 | 100 | mean:55.79;sd:8.35;unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000393 | PGS000116 | 146,573 | 4,471 | 142,102 | 100 | mean:55.8;sd:8.3;unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000394 | PGS000117 | 146,573 | 8,536 | 138,037 | 100 | mean:55.8;sd:8.3;unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000395 | PGS000116 | 205,297 | 1,779 | 203,518 | 0 | mean:56.0;sd:8.01;unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000396 | PGS000117 | 205,297 | 5,158 | 200,139 | 0 | mean:56.0;sd:8.01;unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000397 | PGS000116 | 204,157 | 1,768 | 202,389 | 0 | mean:56.0;sd:8.0;unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000398 | PGS000117 | 204,157 | 5,114 | 199,043 | 0 | mean:56.0;sd:8.0;unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000399 | PGS000116 | 352,660 | 6,272 | 346,388 | 41.8 | mean:55.9;range:[40.0,69.0];unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000400 | PGS000117 | 352,660 | 13,753 | 338,907 | 41.8 | mean:55.9;range:[40.0,69.0];unit:years | European, African unspecified, NR | null | UK | 98.3% White European, 1.7% Black/Other | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | PCE Prospective Cohort (lipid-lowering treatment performed) |
PSS000401 | PGS000116 | 350,730 | 6,239 | 344,491 | 41 | range:[40.0,69.0];unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Coronary artery disease was defined as myocardial infarction and its related sequelae (coronary angioplasty, and coronary artery bypass grafts). ICD-10 codes: I21, I22, I23, I24.1, I25.2 ICD-9 codes: 410, 411, 412, 429.79 OPCS-4 codes: K40.1-4, K41.1-4, K45.1-5, K49.1-2, K49.8-9, K50.2, K75.1-4, K54.8-9 UKBiobank field... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000402 | PGS000117 | 350,730 | 13,650 | 337,080 | 41 | range:[40.0,69.0];unit:years | European, South Asian, African American or Afro-Caribbean, African unspecified, East Asian, Asian unspecified | null | UK | 2,332 Africans, 145 Bangladeshi, 3,165 Carribeans, 1,136 Chinese, 3,790 Indians, 1,258 Other Asians, 1,182 Pakistani, 332,326 White Europeans and Unkown ancestry | Cardiovascular disease was defined as coronary artery disease, and additionally includes angina, nonhemorrhagic stroke, and transient ischemic attack. ICD-10 codes: G45, I20, I21, I22, I23, I24.1, I25, I63. I64 ICD-9 codes: 410, 411, 412, 413, 414, 434, 436 OPCS-4 codes: K40, K41, K42, K43, K44, K45, K46, K47.1, K49, K... | mean:8.01;sd:1.04;unit:years | null | null | null | UKB | QRISK3 Prospective Cohort/Testing Set (lipid-lowering treatment performed) |
PSS000406 | PGS000317 | 12,280 | 4,658 | 7,622 | 0 | mean (age at diagnosis, cases):57.0;sd (age at diagnosis, cases):13.0;unit:years | Hispanic or Latin American | null | USA, Mexico, Colombia, Peru | null | Women with invasive breast cancer were considered cases and those without breast cancer were considered controls. | null | null | null | null | SFBCS|NC-BCFR|RPEGH|MEC|CAMA|COLUMBUS|PEGEN-BC | See supplement for cohort-specific participant recruitment/ascertainment |
PSS000407 | PGS000317 | 2,001 | 2,962 | 2,001 | 0 | null | Hispanic or Latin American | null | Mexico, Colombia, Peru | null | Women with invasive breast cancer were considered cases and those without breast cancer were considered controls. | null | null | null | null | CAMA|COLUMBUS|PEGEN-BC | See supplement for cohort-specific participant recruitment/ascertainment |
PSS000408 | PGS000317 | 7,317 | 1,696 | 5,621 | 0 | null | Hispanic or Latin American | null | USA | null | Women with invasive breast cancer were considered cases and those without breast cancer were considered controls. | null | null | null | null | SFBCS|NC-BCFR|RPEGH|MEC | See supplement for cohort-specific participant recruitment/ascertainment |
PSS000409 | PGS000318 | 60,308 | 1,720 | 58,588 | 0 | mean (baseline):57.2;sd:7.9;unit:years | European | null | null | null | The death registry data were available through November 30, 2016, for the centers in Scotland and January 31, 2018, for the centers in England and Wales. We determined whether an individual died of a particular disease by considering the ICD-10 code listed as the primary cause of death | mean:8.8;sd:1.0;unit:years | null | null | null | UKB | null |
PSS000410 | PGS000319 | 52,074 | 2,784 | 49,290 | 100 | mean (baseline):57.6;sd:8.1;unit:years | European | null | null | null | The death registry data were available through November 30, 2016, for the centers in Scotland and January 31, 2018, for the centers in England and Wales. We determined whether an individual died of a particular disease by considering the ICD-10 code listed as the primary cause of death | mean:8.7;sd:1.3;unit:years | null | null | null | UKB | null |
PSS000411 | PGS000320 | 104 | 76 | 28 | null | null | European | null | null | null | 59 MC4R mutations that had previously been reported to play a role in obesity were included in our analyses (Table S2) All phenotypic data used for analyses were collected at the baseline visit. We provide a brief description here; more details can be found in S1 Text and elsewhere [18–21]. BMI, calculated as weight (k... | null | null | null | null | UKB | null |
PSS000412 | PGS000320 | 256,770 | 109,216 | 147,554 | null | null | European | null | null | null | 59 MC4R mutations that had previously been reported to play a role in obesity were included in our analyses (Table S2) All phenotypic data used for analyses were collected at the baseline visit. We provide a brief description here; more details can be found in S1 Text and elsewhere [18–21]. BMI, calculated as weight (k... | null | null | null | null | UKB | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.